Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Marie Hoffmann ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   6.3% 5.9% 4.1% 5.0% 5.3% 7.0% 11.5% 11.5%   Credit score (0-100)   39 41 49 42 42 33 21 21   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   -0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   746 1,148 1,339 1,317 1,463 1,950 0.0 0.0   EBITDA   -8.7 303 236 168 132 77.9 0.0 0.0   EBIT   -103 206 130 51.9 0.3 -58.6 0.0 0.0   Pre-tax profit (PTP)   -133.8 159.0 99.0 26.2 -24.9 -119.5 0.0 0.0   Net earnings   -104.9 123.4 77.5 21.3 -17.4 -81.8 0.0 0.0   Pre-tax profit without non-rec. items   -134 159 99.0 26.2 -24.9 -119 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   411 374 315 331 366 255 0.0 0.0   Shareholders equity total   -196 -72.9 4.6 25.9 8.5 -73.4 -123 -123   Interest-bearing liabilities   994 796 467 416 582 579 423 423   Balance sheet total (assets)   1,003 911 886 807 833 740 300 300   Net Debt   991 794 418 408 580 561 423 423     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   746 1,148 1,339 1,317 1,463 1,950 0.0 0.0   Gross profit growth   -4.6% 53.9% 16.7% -1.7% 11.1% 33.3% -100.0% 0.0%   Employees   3 2 3 3 4 5 0 0   Employee growth %   50.0% -33.3% 50.0% 0.0% 33.3% 25.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,003 911 886 807 833 740 300 300   Balance sheet change%   -6.5% -9.1% -2.7% -8.9% 3.2% -11.2% -59.5% 0.0%   Added value   -8.7 302.8 236.3 168.0 116.4 77.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -173 -158 -190 -125 -122 -273 -255 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 1.0 2.0 3.0 4.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -13.8% 18.0% 9.7% 3.9% 0.0% -3.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -8.7% 18.9% 13.9% 6.1% 0.0% -7.1% 0.0% 0.0%   ROI %   -10.5% 22.9% 19.8% 11.0% 0.1% -10.0% 0.0% 0.0%   ROE %   -10.1% 12.9% 16.9% 139.4% -101.4% -21.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -16.4% -7.4% 0.5% 3.2% 1.0% -9.0% -29.1% -29.1%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -11,404.0% 262.2% 177.0% 243.1% 437.8% 720.9% 0.0% 0.0%   Gearing %   -506.4% -1,091.7% 10,092.1% 1,604.5% 6,868.0% -788.7% -343.2% -343.2%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.2% 5.3% 4.9% 5.8% 5.1% 10.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.2 0.3 0.1 0.2 0.2 0.0 0.0   Current Ratio   0.2 0.2 0.3 0.2 0.2 0.2 0.0 0.0   Cash and cash equivalent   2.8 2.0 49.3 7.5 2.8 17.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -583.7 -466.2 -323.5 -408.6 -488.8 -513.7 -211.7 -211.7   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -3 151 79 56 29 16 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -3 151 79 56 33 16 0 0   EBIT / employee   -34 103 43 17 0 -12 0 0   Net earnings / employee   -35 62 26 7 -4 -16 0 0